Lipid rafts are required for signal transduction by angiotensin II receptor type 1 in neonatal glomerular mesangial cells

Experimental Cell Research

Volumn 324, Issue 1, 2014, Pages 92-104

  Adebiyi, Adebowale ^a   Soni, Hitesh ^a   John, Theresa A ^a   Yang, Fen ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II; Caveolin 1 scaffolding domain; Glomerular mesangial cells; Intracellular calcium; Lipid rafts; Proliferation

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR TYPE 1; CALCIUM; CAVEOLIN 1; CHOLESTEROL; CSD PEPTIDE; CYCLODEXTRIN; EMD 66684; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CELL ASSAY; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEPLETION; GLOMERULAR MESANGIAL CELL; GLOMERULUS; IN SITU PROXIMITY LIGATION ASSAY; LIPID RAFT; MALE; MESANGIUM CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SWINE;

CHICKEN ANEMIA VIRUS; SUIDAE; SUS;

ANGIOTENSIN II; CAVEOLIN-1 SCAFFOLDING DOMAIN; GLOMERULAR MESANGIAL CELLS; INTRACELLULAR CALCIUM; LIPID RAFTS; PROLIFERATION;

ANIMALS; ANIMALS, NEWBORN; CALCIUM; CELL MEMBRANE; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MEMBRANE MICRODOMAINS; MESANGIAL CELLS; PRIMARY CELL CULTURE; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; SWINE;

EID: 84899484572     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.03.011     Document Type: Article

References (81)

1. 2+ elevation and contraction in glomerular mesangial cells. J. Cell Physiol. 2014, 229:502-511.
2. Adebiyi A., Narayanan D., Jaggar J.H. Caveolin-1 assembles type 1 inositol 1,4,5-trisphosphate receptors and canonical transient receptor potential 3 channels into a functional signaling complex in arterial smooth muscle cells. J. Biol. Chem. 2011, 286:4341-4348.
3. 3 receptors in smooth muscle cells regulates arterial contractility. Circ. Res. 2010, 106:1603-1612.
4. Arendshorst W.J., Brannstrom K., Ruan X. Actions of angiotensin II on the renal microvasculature. J. Am. Soc. Nephrol. 1999, 10(Suppl. 11):S149-S161.
5. Beech D.J. Integration of transient receptor potential canonical channels with lipids. Acta Physiol. 2012, 204:227-237.
6. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 1993, 361:315-325.
7. Berridge M.J. Calcium signalling and cell proliferation. Bioessays 1995, 17:491-500.
8. Blankley C.J., Hodges J.C., Klutchko S.R., Himmelsbach R.J., Chucholowski A., Connolly C.J., Neergaard S.J., Van Nieuwenhze M.S., Sebastian A., Quin J. Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J. Med. Chem. 1991, 34:3248-3260.
9. Cameron J.S. Lupus nephritis. J. Am. Soc. Nephrol. 1999, 10:413-424.
10. Chevalier R.L. Developmental renal physiology of the low birth weight pre-term newborn. J. Urol. 1996, 156:714-719.
11. Chini B., Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?. J. Mol. Endocrinol. 2004, 32:325-338.
12. Cho H., Kozasa T., Bondjers C., Betsholtz C., Kehrl J.H. Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J. 2003, 17:440-442.
13. Ciuffo G.M., Viswanathan M., Seltzer A.M., Tsutsumi K., Saavedra J.M. Glomerular angiotensin II receptor subtypes during development of rat kidney. Am. J. Physiol. 1993, 265:F264-F271.
14. Couet J., Li S., Okamoto T., Ikezu T., Lisanti M.P. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 1997, 272:6525-6533.
15. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994, 269:10444-10450.
16. Dreja K., Voldstedlund M., Vinten J., Tranum-Jensen J., Hellstrand P., Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1267-1272.
17. Du J., Sours-Brothers S., Coleman R., Ding M., Graham S., Kong D.H., Ma R. Canonical transient receptor potential 1 channel is involved in contractile function of glomerular mesangial cells. J. Am. Soc. Nephrol. 2007, 18:1437-1445.
18. Fra A.M., Williamson E., Simons K., Parton R.G. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. U.S.A 1995, 92:8655-8659.
19. Fujita A., Cheng J., Tauchi-Sato K., Takenawa T., Fujimoto T. A distinct pool of phosphatidylinositol 4,5-bisphosphate in caveolae revealed by a nanoscale labeling technique. Proc. Natl. Acad. Sci. U.S.A 2009, 106:9256-9261.
20. Gao J., Chao J., Parbhu K.J., Yu L., Xiao L., Gao F., Gao L. Ontogeny of angiotensin type 2 and type 1 receptor expression in mice. J. Renin-Angiotensin-Aldosterone Syst. 2012, 13:341-352.
21. Garcia-Cardena G., Martasek P., Masters B.S., Skidd P.M., Couet J., Li S., Lisanti M.P., Sessa W.C. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J. Biol. Chem. 1997, 272:25437-25440.
22. 2+ signaling in glomerular mesangial cells in diabetes. Am. J. Physiol. Ren. Physiol. 2007, 293:F1381-F1390.
23. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
24. He M., Zhang L., Shao Y., Xue H., Zhou L., Wang X.F., Yu C., Yao T., Lu L.M. Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression. Mol. Cell Endocrinol. 2010, 315:188-194.
25. Hilgers K.F., Norwood V.F., Gomez R.A. Angiotensin[U+05F3]s role in renal development. Semin. Nephrol. 1997, 17:492-501.
26. Hook J.B., Bailie M.D. Perinatal renal pharmacology. Annu. Rev. Pharmacol. Toxicol. 1979, 19:491-509.
27. Hua H., Munk S., Whiteside C.I. Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am. J. Physiol. Ren. Physiol. 2003, 284:F303-F312.
28. Huckle W.R., Earp H.S. Regulation of cell proliferation and growth by angiotensin II. Prog. Growth Factor Res. 1994, 5:177-194.
29. Ishizaka N., Griendling K.K., Lassegue B., Alexander R.W. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 1998, 32:459-466.
30. Iversen B.M., Kvam F.I., Matre K., Morkrid L., Horvei G., Bagchus W., Grond J., Ofstad J. Effect of mesangiolysis on autoregulation of renal blood flow and glomerular filtration rate in rats. Am. J. Physiol. 1992, 262:F361-F366.
31. Jung N.H., Kim H.P., Kim B.R., Cha S.H., Kim G.A., Ha H., Na Y.E., Cha Y.N. Evidence for heme oxygenase-1 association with caveolin-1 and -2 in mouse mesangial cells. IUBMB Life 2003, 55:525-532.
32. Kaschina E., Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press. 2003, 12:70-88.
33. Kilsdonk E.P., Yancey P.G., Stoudt G.W., Bangerter F.W., Johnson W.J., Phillips M.C., Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 1995, 270:17250-17256.
34. 2+ influx by binding of its scaffolding domain to transient receptor potential channel-1 in endothelial cells. Mol. Pharmacol. 2006, 70:1174-1183.
35. Lai K.N., Chan L.Y., Tang S.C., Tsang A.W., Li F.F., Lam M.F., Lui S.L., Leung J.C. Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int. 2004, 66:1403-1416.
36. Leclerc P.C., Auger-Messier M., Lanctot P.M., Escher E., Leduc R., Guillemette G. A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling. Endocrinology 2002, 143:4702-4710.
37. Linder A.E., Thakali K.M., Thompson J.M., Watts S.W., Webb R.C., Leite R. Methyl-beta-cyclodextrin prevents angiotensin II-induced tachyphylactic contractile responses in rat aorta. J. Pharmacol. Exp. Ther. 2007, 323:78-84.
38. Manders E.M.M., Verbeek F.J., Aten J.A. Measurement of co-localization of objects in dual-colour confocal images. J. Microsc. 1993, 169:375-382.
39. Matsui K., Breiteneder-Geleff S., Kerjaschki D. Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes. J. Am. Soc. Nephrol. 1998, 9:2013-2026.
40. Mederski W.W., Dorsch D., Bokel H.H., Beier N., Lues I., Schelling P. Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives. J. Med. Chem. 1994, 37:1632-1645.
41. 2+ kinetics evoked by angiotensin II in human vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2007, 293:C1953-C1961.
42. Mene P., Simonson M.S., Dunn M.J. Physiology of the mesangial cell. Physiol. Rev. 1989, 69:1347-1424.
43. Okamoto T., Schlegel A., Scherer P.E., Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 1998, 273:5419-5422.
44. Ostrom R.S., Liu X. Detergent and detergent-free methods to define lipid rafts and caveolae. Methods Mol. Biol. 2007, 400:459-468.
45. Parpal S., Karlsson M., Thorn H., Stralfors P. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control. J. Biol. Chem. 2001, 276:9670-9678.
46. Patel H.H., Murray F., Insel P.A. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu. Rev. Pharmacol. Toxicol. 2008, 48:359-391.
47. Peng F., Zhang B., Wu D., Ingram A.J., Gao B., Krepinsky J.C. TGFbeta-induced RhoA activation and fibronectin production in mesangial cells require caveolae. Am. J. Physiol. Ren. Physiol. 2008, 295:F153-F164.
48. Pike L.J. Lipid rafts: bringing order to chaos. J. Lipid Res. 2003, 44:655-667.
49. Ray P.E., Aguilera G., Kopp J.B., Horikoshi S., Klotman P.E. Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells. Kidney Int. 1991, 40:764-771.
50. Ray P.E., Bruggeman L.A., Horikoshi S., Aguilera G., Klotman P.E. Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int. 1994, 45:177-184.
51. Razani B., Woodman S.E., Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 2002, 54:431-467.
52. Ruster C., Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J. Am. Soc. Nephrol. 2006, 17:2985-2991.
53. Scheiffele P., Verkade P., Fra A.M., Virta H., Simons K., Ikonen E. Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J. Cell Biol. 1998, 140:795-806.
54. Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., Tinevez J.Y., White D.J., Hartenstein V., Eliceiri K., Tomancak P., Cardona A. Fiji: an open-source platform for biological-image analysis. Nat. Methods 2012, 9:676-682.
55. Schlondorff D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J. 1987, 1:272-281.
56. Schlondorff D., Banas B. The mesangial cell revisited: no cell is an island. J. Am. Soc. Nephrol. 2009, 20:1179-1187.
57. Sethi S., Fervenza F.C. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin. Nephrol. 2011, 31:341-348.
58. Shenoy S.K., Lefkowitz R.J. Angiotensin II-stimulated signaling through G proteins and beta-arrestin. Sci. STKE 2005, 2005:cm14.
59. Shukla A.K., Xiao K., Lefkowitz R.J. Emerging paradigms of beta-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem. Sci. 2011, 36:457-469.
60. Soderberg O., Gullberg M., Jarvius M., Ridderstrale K., Leuchowius K.J., Jarvius J., Wester K., Hydbring P., Bahram F., Larsson L.G., Landegren U. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 2006, 3:995-1000.
61. Soh U.J., Trejo J. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through beta-arrestin and dishevelled-2 scaffolds. Proc. Natl. Acad. Sci. U.S.A 2011, 108:E1372-E1380.
62. Soni H., Adebiyi A. Pressor and renal regional hemodynamic effects of urotensin II in neonatal pigs. J. Endocrinol. 2013, 217:317-326.
63. Sowa G., Pypaert M., Sessa W.C. Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc. Natl. Acad. Sci. U.S.A 2001, 98:14072-14077.
64. Steffes M.W., Osterby R., Chavers B., Mauer S.M. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989, 38:1077-1081.
65. Stockand J.D., Sansom S.C. Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease. Am. J. Kidney Dis. 1997, 29:971-981.
66. Stockand J.D., Sansom S.C. Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol. Rev. 1998, 78:723-744.
67. 2+ entry in endothelial cells. Am. J. Physiol. Cell Physiol. 2009, 296:C403-C413.
68. Tamai O., Oka N., Kikuchi T., Koda Y., Soejima M., Wada Y., Fujisawa M., Tamaki K., Kawachi H., Shimizu F., Kimura H., Imaizumi T., Okuda S. Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis. Kidney Int. 2001, 59:471-480.
69. Thathiah A., Horre K., Snellinx A., Vandewyer E., Huang Y., Ciesielska M., De K.G., Munck S., De S.B. Beta-arrestin 2 regulates Abeta generation and gamma-secretase activity in Alzheimer[U+05F3]s disease. Nat. Med. 2013, 19:43-49.
70. Touyz R.M., Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 2000, 52:639-672.
71. Ushio-Fukai M., Alexander R.W. Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle. Hypertension 2006, 48:797-803.
72. Ushio-Fukai M., Hilenski L., Santanam N., Becker P.L., Ma Y., Griendling K.K., Alexander R.W. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J. Biol. Chem. 2001, 276:48269-48275.
73. 2+/calmodulin-dependent protein kinase II stimulates c-fos transcription and DNA synthesis by a Src-based mechanism in glomerular mesangial cells. J. Am. Soc. Nephrol. 2003, 14:28-36.
74. Wolf G., Neilson E.G. Angiotensin II as a renal growth factor. J. Am. Soc. Nephrol. 1993, 3:1531-1540.
75. Woods L.L., Rasch R. Perinatal ANG II programs adult blood pressure, glomerular number, and renal function in rats. Am. J. Physiol. 1998, 275:R1593-R1599.
76. Wyse B.D., Prior I.A., Qian H., Morrow I.C., Nixon S., Muncke C., Kurzchalia T.V., Thomas W.G., Parton R.G., Hancock J.F. Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J. Biol. Chem. 2003, 278:23738-23746.
77. 2+ release. Circ. Res. 2008, 102:1118-1126.
78. Xue H., Yuan P., Zhou L., Yao T., Huang Y., Lu L.M. Effect of adrenotensin on cell proliferation is mediated by angiotensin II in cultured rat mesangial cells. Acta Pharmacol. Sin. 2009, 30:1132-1137.
79. Yu L., Zheng M., Wang W., Rozanski G.J., Zucker I.H., Gao L. Developmental changes in AT1 and AT2 receptor-protein expression in rats. J. Renin-Angiotensin-Aldosterone Syst. 2010, 11:214-221.
80. 2+/calmodulin-dependent and cAMP-dependent kinases in induction of c-fos in human mesangial cells. Am. J. Physiol. Ren. Physiol. 2002, 283:F888-F894.
81. Zhang A., Ding G., Huang S., Wu Y., Pan X., Guan X., Chen R., Yang T. c-Jun NH2-terminal kinase mediation of angiotensin II-induced proliferation of human mesangial cells. Am. J. Physiol. Ren. Physiol. 2005, 288:F1118-F1124.